Pfizer Adds Earnings Warnings Ahead of FDA FOIA Release of Test Results
Could the end be near?
Pfizer snuck some bombshells into its latest earnings reports. As ZeroHedge reports:
Now, Pfizer - which just forecast $54 billion in Covid-related sales in 2022, appears to be anticipating some bad news, as evidenced by several redline changes in their Q4 earnings releases.
Pfizer warns investors that information related to “disclosure” of vaccine safety issues, particularly related to pre-clinical, clinical, or safety data.
This comes after a Texas judge ordered the FDA to accelerate release of testing data from Pfizer’s Covid vaccine trials. The FDA and Pfizer wanted 75 years to release the data; the judge gave them nine months.
On Monday, The Gateway Pundit reported that the judge did grant a temporary delay to the FDA in producing its first tranche of documents.
In yet another delay, a Federal Judge issued an order that changes the US Food and Drug Administration (FDA) release schedule for the Freedom of Information Act (FOIA) request that requires the agency to begin turning over all of the 450,000-plus documents that were analyzed in its decision to approve Pfizer’s Covid-19 vaccine.
So, it looks like Pfizer knows that data dump will be ugly. And will continue to be ugly through November.
Makes you wonder if that’s why so many mask and vaccine mandates are going away all of a sudden.
California is ending its mask mandate next Tuesday, February 15.
Delaware and New Jersey are ending their school mask mandates.
Have the oligarchs gotten the message?